EXCLUSIVE - ‘Fighting cancer knows no borders': Prof. Bourhis on Egypt-France cancer care partnership - Health - Life & Style
In this interview, conducted shortly before he departed from Cairo on 27 June, Professor Bourhis reflected on the significance of international partnerships in oncology and the shared commitment to expanding access to high-quality cancer care.
During his visit on 25 and 26 June, he conducted free consultations and medical examinations for patients with leukaemia, lymphoma, and multiple myeloma. The trip formed part of a broader collaboration between France and Egypt, following an agreement signed in April by Egypt's Minister of Health Khaled Abdel Ghaffar and Gustave Roussy CEO Prof. Fabrice Barlesi to establish the French institute's first international oncology centre in Cairo — a project endorsed by Presidents Abdel-Fattah El-Sisi and Emmanuel Macron.
Ahram Online (AO): Professor Bourhis, what inspired this visit to Egypt?
Dr Jean-Henri Bourhis (JB): It's part of Gustave Roussy's international mission. Since our founding in 1922, we've believed in a multidisciplinary approach to cancer treatment. That includes forming meaningful, long-term partnerships with other institutions. Egypt is now one of those key partners.
AO: As part of the Gustave Roussy institution, what does it mean to you, personally, to be part of this collaboration?
JB: In France, we value liberty, equality, and fraternity—and those principles apply to science. We believe in sharing innovation. Cancer doesn't care about borders or languages, so neither should we. This visit reflects that spirit.
I visited two hospitals and met impressive medical teams. Their knowledge, enthusiasm, and professionalism were clear. We discussed complex haematology cases, including multiple myeloma, leukaemias, and other conditions.
AO: What is your impression of cancer treatment during the visit?
JB: Very positive. Diagnostic and treatment protocols are well-managed. Egyptian teams are skilled in applying prognostic factors and therapeutic strategies effectively. That's a very solid foundation.
AO: Where do you see the main challenges?
JB: The talent is here; the will is here. However, some factors—such as sterile airflow rooms and air and water treatment systems—require ongoing investment. That's essential for advanced therapies and infection control.
While academic research plays a significant role, much of the innovation also comes from biotech and pharmaceutical companies. These companies are brilliant, but they are driven by profit. So, we need to strike a balance between academic research and corporate-led research to avoid potential pitfalls or limitations.
Clinical research is a key point. The shift must be from 'excellent care' to 'excellent care + clinical research.' That requires standardized treatment protocols, centralized data systems, and a team-wide mindset change. The tools are there, but the framework needs to be structured.
AO: Could this new Gustave Roussy partnership transform cancer care in the region?
JB: Absolutely. This initiative can serve as a model for others to follow. We're not replacing what Egyptian doctors and hospitals are already doing—on the contrary, we're supporting and amplifying it. By building secure patient data systems and treatment pathways, we can improve survival rates. Many children with leukaemia may not receive the full treatment or discontinue it due to systemic issues. That's something we must address.
AO: What is the role of AI in your field today?
JB: AI is a powerful tool in both diagnosis and treatment planning. It can detect patterns across imaging, molecular data, and patient history, identifying rare subtypes and predicting responses. In imaging, AI assists radiologists with complex scans. It's exciting and transformative.
AO: Let's talk data. How important is it in cancer care and research?
JB: It's foundational. Without data, there's no research. We need digital, accessible databases to track treatments, responses, and long-term outcomes—not just within one hospital but nationally. Registries help us know what's happening with different types of cancer across the country.
AO: A tough question — what are your top three pieces of advice to avoid cancer?
JB: Avoiding known carcinogens such as tobacco, excessive alcohol, and unhealthy diets is crucial in reducing cancer risk. It's also essential to undergo early screening, particularly for individuals with a family history of cancer, as timely detection can save lives. Lastly, trusting in multidisciplinary care is key—collaboration among doctors from various specialities often leads to the most effective treatment strategies.
AO: Does mental health influence cancer development?
JB: Not directly. However, lifestyle and stress influence behaviour, including diet, sleep, and physical activity, all of which impact overall health. Mental well-being is indirectly related to cancer prevention.
AO: Any final thoughts before you leave?
JB: I'm truly glad about the partnership between our institution and the Egyptian medical community. It's not just a symbolic or virtual link—we're building real connections. Egypt is a key partner for us moving forward. The people here are highly educated, enthusiastic, and full of potential. The country can become a central hub for excellence in cancer care in the region. We hope to support clinical care and help launch more robust clinical research projects.
Egypt's medical network is evolving from strong clinical practice into research excellence—and that's the future.
Follow us on:
Short link:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
2 days ago
- Daily News Egypt
Aid airdrops intensify as famine deepens in Gaza amid mounting international criticism
Egyptian military aircraft have airdropped humanitarian aid over the Gaza Strip for the second day in a row, as fears mount of an imminent humanitarian catastrophe driven by famine. On Tuesday, Egyptian planes targeted central Gaza, focusing on the city of Deir al-Balah, which shelters over 150,000 displaced Palestinians. At the same time, Saudi relief efforts continued on the ground. On Wednesday, seven more trucks crossed through the Rafah crossing carrying food aid from the King Salman Humanitarian Aid and Relief Center. According to the Saudi Press Agency (SPA), the total volume of Saudi aid delivered to Gaza has now reached 7,188 tonnes, including 20 ambulances. However, the Central Emergency Committee in Gaza voiced frustration over official Egyptian claims about aid volumes, arguing that the reported daily entry of hundreds of trucks does not reflect the actual situation observed by local authorities. The committee called for the immediate, unconditional reopening of the Rafah crossing and denounced the 'complicated and humiliating coordination process' that continues to block the entry of vital medical supplies and fuel. In parallel, Belgium announced it will join the international airdrop initiative coordinated by Jordan, sending a plane with medical and food supplies valued at around €600,000 (approximately $690,000). The aircraft will remain stationed in Jordan, ready for coordinated deliveries into Gaza. Meanwhile, Gaza's Ministry of Health reported seven more deaths from famine within the past 24 hours, raising the total famine-related death toll to 154, including 89 children. The territory remains under a severe blockade, with limited and sporadic humanitarian access. On the military front, Al-Qassam Brigades claimed responsibility for targeting an Israeli military position in Khan Younis with three 'barrel bombs,' stating the attack caused casualties among Israeli troops. Inside Israel, the conflict's toll on soldiers has become increasingly visible: Haaretz reported a sharp increase in suicides among Israeli soldiers and officers, with 24 taking their own lives in 2024, seven of them since the start of the war on Gaza. The newspaper cited a shortage of mental health professionals and inadequate psychological support as contributing factors. Controversy also erupted in Israel after Heritage Minister Amichai Eliyahu suggested reclassifying Israeli hostages held in Gaza as 'prisoners of war' and postponing efforts to secure their release until Israel achieves military victory. His remarks provoked strong backlash from the public and relatives of the captives. Separately, Morocco's Foreign Ministry announced that King Mohammed VI had formally requested Israeli Prime Minister Benjamin Netanyahu to allow Moroccan humanitarian aid to enter Gaza via Israel's Ben Gurion Airport and then through the Kerem Shalom crossing. At the United Nations, the Office of the High Commissioner for Human Rights warned that Israeli settlement expansion in the occupied West Bank appears aimed at forcibly displacing Palestinians. The UN called on Israel to halt violence, discriminatory practices, and its continued occupation of Palestinian territories, reiterating that all settlements in the West Bank are illegal under international law. UN Special Rapporteur Francesca Albanese, meanwhile, expressed deep concern over US sanctions imposed on her for her outspoken criticism of the war in Gaza. Speaking from Rome to the Associated Press, Albanese described the sanctions as 'a dangerous development' that could hinder her work. On the diplomatic front, more than 20 countries attending the International Conference on the Two-State Solution in New York issued a joint statement reaffirming their vision for a peaceful resolution. Co-chaired by France and Saudi Arabia, and supported by Egypt, the EU, and others, the statement underscored the need for a viable Palestinian state. Malta's Prime Minister Robert Abela announced that his country will officially recognise the State of Palestine during the upcoming UN General Assembly session, following similar announcements by Britain and France.
Daily News Egypt
3 days ago
- Daily News Egypt
Boehringer Ingelheim partners with General Organization of Veterinary Services to ‘Stop Rabies' in Egypt
In a first-of-its-kind public-private partnership, the General Organization of Veterinary Services (GOVS) and Boehringer Ingelheim, a leading research-driven biopharmaceutical company have signed a Memorandum of Understanding (MoU) to advance efforts to eliminate dog-mediated human rabies. This partnership aims to address public health risks associated with rabies in Egypt. The signing of this agreement reflects a shared commitment across government and institutional stakeholder to protect the health of Egyptian citizens and maintain environmental and public health balance throughout the country. Egypt has made progress in combating zoonotic diseases through vaccination campaigns, awareness efforts, and the expansion of cooperation protocols with partners from the private sector and civil society. The GOVS, emphasizes the importance of cross-sector partnerships, which combine scientific and practical expertise with logistical and administrative support to achieve effective and sustainable results in reducing the spread of rabies—particularly in rural areas and regions with high animal density. Rabies is a viral zoonotic disease that attacks the central nervous system and is fatal once clinical symptoms appear. Transmitted primarily through dog bites, it remains a preventable yet deadly global threat, causing around 59,000 human deaths worldwide each year. The agreement, signed on July 22 at the GOVS headquarters in Ismailia, marks a significant step in addressing the ongoing threat of rabies on the Egyptian community. The MoU was signed by Dr. Hamed Moussa Al-Aqnas, Chairman of the General Organization for Veterinary Services and Mahmoud El Mahdy, Country Head of Animal Health for North, East, and West Africa at Boehringer Ingelheim. Dr. Hamed Moussa Al-Aqnas, Chairman of the General Organization for Veterinary Services said: 'Rabies remains one of the most serious public health threats, despite being preventable. At GOVs, we are committed to promoting the health and well-being of animals in Egypt, while also safeguarding human health from animal-related diseases. Through stronger cross-sector collaboration and by aligning with the global strategy to eliminate rabies by 2030, we aim to advance Egypt's national response and deliver sustainable impact. ' 'Public engagement is a key component in rabies elimination efforts. We aim to increase the community's understanding of how rabies is transmitted and the serious risks it poses, with a particular focus on protecting our youth who are among the most vulnerable and often come into contact with stray dogs during play. In parallel, we are committed to promoting responsible pet ownership by emphasizing the importance of vaccinating domestic dogs to safeguard both their owners and the wider community,' added Dr. Moussa. Following the agreement, GOVS and Boehringer Ingelheim will be the primary drivers of the 'Elimination of Dog-Mediated Human Rabies', an initiative by the Ministry of Agriculture and Land Reclamation (MoALR). The two parties will collaborate to conduct comprehensive vaccination campaigns targeting stray dogs against rabies across Egypt, starting in Ismailia. 'Despite being a vaccine-preventable disease, rabies continues to be a global threat and is responsible for the death of thousands of people every year, with a large proportion of victims being children. As a global leader in rabies prevention, we have the expertise and tools needed to support rabies elimination efforts and help protect communities from dog-mediated rabies. However, our impact is greatly amplified through strategic public partnerships that empower us to drive greater change. We look forward to working closely with the General Organization of Veterinary Services to address the threat of rabies in Egypt and help safeguard both children and adults from this devastating disease, contributing to a healthier and safer environment for both humans and dogs,' said Mahmoud El Mahdy, Country Head of Animal Health for North, East, and West Africa at Boehringer Ingelheim. In addition to conducting rabies vaccination campaigns, the agreement includes raising awareness about rabies, its dangers, and the importance of prevention. This will be achieved through various mediums, including local community events and educational programs in academic settings. The partnership is part of Boehringer Ingelheim's global 'Stop Rabies' initiative, which aims to eliminate dog-mediated rabies through a holistic approach focused on vaccination, education, and surveillance. With a commitment to providing 500 million vaccine doses and educating 15 million children by 2038, the company is working closely with governments, NGOs, veterinarians, and communities to address the disease at its source. In Egypt, this partnership with GOVS marks a critical step toward that global goal, starting in Ismailia and aiming to create long-term, community-driven impact. Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at Boehringer Ingelheim – Life Forward | Boehringer Ingelheim .
Egypt Independent
3 days ago
- Egypt Independent
Renowned Egyptian actor Lotfy Labib passes away at 77
Veteran Egyptian actor Lotfy Labib passed away on Wednesday morning at the age of 77. His health had rapidly deteriorated after he suffered a severe laryngeal hemorrhage due to pneumonia. The late actor had recently clarified his prolonged absence, emphasizing that he wasn't on a voluntary break but rather facing a reality imposed by his health conditions. 'I'm not on vacation… I've had a brain clot for seven years now, and in the past eight years, I might have worked one day a year. I think that's called retirement,' he had stated. Labib had been hospitalized days prior and was moved to the intensive care unit due to severe inflammation in his larynx and lungs, which completely prevented him from speaking. This further worsened his condition. Fans had been anxiously awaiting his recovery and his customary reassurances. Director Mohamed Al Deeb, Labib's business manager, announced the date and location of the funeral: 'The funeral will be tomorrow at noon from St. Mark's Coptic Orthodox Cathedral in Heliopolis.'
